• Fund Type: SICAV
  • Objective: Foreign Blend
  • Asset Class: Equity
  • Geographic Focus: International

JPMorgan Funds - Global Unconstrained Equity Fund

+ Add to Watchlist

JPMGLEX:LX

14.27 USD 0.10 0.71%

As of 00:59:30 ET on 12/19/2014.

Snapshot for JPMorgan Funds - Global Unconstrained Equity Fund (JPMGLEX)

Year To Date: +6.25% 3-Month: -2.26% 3-Year: +17.33% 52-Week Range: 12.73 - 14.66
1-Month: -0.14% 1-Year: +9.77% 5-Year: +9.26% Beta vs MXWD000V: 1.03

Mutual Fund Chart for JPMGLEX

No chart data available.
  • JPMGLEX:LX 14.27
  • 1M
  • 1Y
Interactive JPMGLEX Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for JPMGLEX

JPMorgan Funds - Global Unconstrained Equity Fund is an open-end investment fund incorporated in Luxembourg. The Fund's objective is to provide long-term capital growth. The Fund invests primarily in equities, throughout the world. The Fund may invest, to a limited extent, in fixed-interest securities.

Inception Date: 03-21-2006 Telephone: 352-34-10-101 Tel
Managers: PETER KIRKMAN / TIM WOODHOUSE
Web Site: www.jpmorganassetmanagement.com

Fundamentals for JPMGLEX

NAV (on 2014-12-19) 14.27
Assets (M) (on 2014-12-19) 374.41
Fund Leveraged N
Minimum Investment 0.00
Minimum Subsequent Investment 0.00

Dividends for JPMGLEX

No dividends reported

Fees & Expenses for JPMGLEX

Front Load 0.00
Back Load 0.00
Current Mgmt Fee 0.00
Redemption Fee 0.00
12b1 Fee -
Expense Ratio 0.15

Top Fund Holdings for JPMGLEX

Filing Date: 08/31/2014
Name Position Value % of Total
JPMorgan Liquidity Funds - US 14,981,874 14,981,874 3.836%
Citigroup Inc 275,638 14,236,703 3.645%
Barclays PLC 3,049,728 11,418,672 2.924%
Johnson & Johnson 105,504 10,995,627 2.815%
Sanofi 96,283 10,589,801 2.711%
AXA SA 379,197 9,415,166 2.411%
Novartis AG 99,101 8,910,812 2.281%
QUALCOMM Inc 113,732 8,688,442 2.225%
Teradyne Inc 393,836 8,109,083 2.076%
Boston Scientific Corp 634,524 8,045,764 2.060%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil